Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Jennifer L. McNeer

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of McNeer, Jennifer L.

PropertyValue
overview Jennifer McNeer, MD, MS, treats patients with all types of blood disorders and childhood cancers. She has a particular interest in the treatment of benign and malignant hematological diseases, including pediatric, adolescent, and young adult leukemia and lymphoma. Dr. McNeer is a clinical researcher, focusing on improving treatment strategies for high-risk leukemia patients. She is an active member of the Acute Lymphoblastic Leukemia Committee within the Children's Oncology Group, and is co-director of the University of Chicago Adolescent and Young Adult Oncology Program.

One or more keywords matched the following items that are connected to McNeer, Jennifer L.

Item TypeName
Concept Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Concept Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Concept Precursor Cell Lymphoblastic Leukemia-Lymphoma
Academic Article The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
Academic Article Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia.
Academic Article The complex interplay between folate metabolism and risk of acute lymphoblastic leukemia.
Academic Article Acute lymphoblastic leukemia in young adults: which treatment?
Academic Article RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.
Academic Article Pediatric Acute Lymphoblastic Leukemia: From Diagnosis to Prognosis.
Academic Article Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL).
Academic Article Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Academic Article Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.
Academic Article Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
Academic Article Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature.
Academic Article Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group.
Academic Article Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
Academic Article Cutting to the Front of the Line: Immunotherapy for Childhood Acute Lymphoblastic Leukemia.
Academic Article How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment.
Academic Article Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia.
Academic Article Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.
Academic Article Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia.
Academic Article MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia.

Search Criteria
  • Acute Lymphoblastic Leukemia